Skip to content
value.today

CARGO Therapeutics, Inc.

🇺🇸 San Mateo, California, USABiotechnologyFounded 2019

Formerly Syncopation Life Sciences, Inc.

Total raised
$69 M
1 round on record
Latest round
$69 M
Feb 2023
First round on record
Feb 2023
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CARGO Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2023$69 MNo. 1$50 to $250 million

CARGO Therapeutics, Inc.: Raise no. 1, Feb 2023

Investors in this round

19 investors had bought by the notice of Mar 1, 2023: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for CARGO Therapeutics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$69 M of $201 M offered; $132 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anup Radhakrishnan · Executive Officer
  • Gina Chapman · Executive Officer, Director
  • Abraham Bassan · Director
  • Cassandra Gianna Luca · Director
  • Crystal Mackall · Director
  • Heath Lukatch · Director
  • Jeffrey Walsh · Director
  • John Orwin · Director
  • Krishnan Viswanadhan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gina Chapman, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 1, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CARGO Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2023).

    SEC Form D · Mar 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2023

That is all the official record says: CARGO Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

11 named in official filings. Open an investor to see everything it has backed.

Investors in CARGO Therapeutics, Inc.
InvestorKindAmountRoundRoleSource
Perceptive Advisors LLCFund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Perceptive Xontogeny Venture Fund II, LPVenture capitalnot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Samsara BioCapital GP, LLCOthernot statednot statedHeld Series Seed, A-1 and A-2 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Samsara BioCapital, L.P.Fund or asset managernot statednot statedHeld Series Seed, A-1 and A-2 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Third Rock Ventures GP VI, L.P.Venture capitalnot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Third Rock Ventures GP V, LPVenture capitalnot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Third Rock Ventures VI, L.P.Venture capitalnot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Third Rock Ventures V, L.P.Venture capitalnot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
TRV GP Vi, LLCFund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Trv Gp V, LLCFund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Fund or asset managernot statednot statedHeld Series A-1 preferred stock, 10% owner (Form 3, 2023)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CARGO Therapeutics, Inc.
NameRoleNamed in
Anup RadhakrishnanExecutive officerMar 2023
Gina ChapmanExecutive officerMar 2023
Abraham BassanDirectorMar 2023
Cassandra Gianna LucaDirectorMar 2023
Crystal MackallDirectorMar 2023
Gina ChapmanDirectorMar 2023
Heath LukatchDirectorMar 2023
Jeffrey WalshDirectorMar 2023
John OrwinDirectorMar 2023
Krishnan ViswanadhanDirectorMar 2023